The Role of Chest Ultrasound in Patients With Respiratory Tract Infections (REPSECO)
Observational Study on the Role of Chest Ultrasound in Patients With Respiratory Tract Infections
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Antonio Gatto
- Phone Number: +390630155940
- Email: antonio.gatto@policlinicogemelli.it
Study Locations
-
-
Lazio
-
Rome, Lazio, Italy, 00168
- Fondazione Policlinico Universitario A. Gemelli IRCCS UOSD Pronto Soccorso Pediatrico
-
Contact:
- Antonio Gatto
- Phone Number: +390630155940
- Email: antonio.gatto@policlinicogemelli.it
-
Contact:
- Lorenzo Di Sarno
- Email: lorenzo.disarno1@guest.policlinicogemelli.it
-
Principal Investigator:
- Antonio Gatto
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 0 to 20 years with a clinical diagnosis of respiratory tract infection, evaluated in the emergency department and then discharged home or admitted to the Pediatric Intensive Care Unit or Pediatrics Department.
- Informed consent signed by parents or patient of legal age
Exclusion Criteria:
- Refusal to sign informed consent
- Patients with bronchopulmonary dysplasia
- Foreign body aspiration cases
- Patients with pulmonary malformations
- Patients with neuromuscular diseases
- Patients with hemodynamically significant congenital heart disease
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The ultrasound pattern of patients with respiratory tract infections
Time Frame: 1 hour
|
To evaluate the ultrasound pattern of patients with respiratory tract infections by score.
|
1 hour
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the duration of hospitalization
Time Frame: 1 hour
|
Validate a qualitative and quantitative ultrasound protocol to assess respiratory tract infections to predict the duration of hospitalization
|
1 hour
|
|
Use the SatO2/FiO2 ratio to evaluate outcome
Time Frame: 20 minutes
|
Use the SatO2/FiO2 ratio in conjunction with clinical assessment to evaluate the initiation of respiratory assistance with high-flow oxygen
|
20 minutes
|
|
correlation between ultrasound score and vital parameters
Time Frame: 1 hour
|
Assess a correlation between ultrasound score and vital parameters (FR, HR, SatO2)
|
1 hour
|
|
correlation between ultrasound score and indices of inflammation
Time Frame: 1 hour
|
Assess a correlation between ultrasound score and indices of inflammation (PCR, PCT)
|
1 hour
|
|
correlation between ultrasound parameters and etiology
Time Frame: 2 days
|
Evaluate a possible correlation between ultrasound parameters (paravertebral consolidations, multiple confluent B-lines, white lung) and etiology (positive virus swab for VRS or other respiratory viruses)
|
2 days
|
|
possible correlations between various epidemiologic and clinical data
Time Frame: 2 hours
|
Assess possible correlations between various epidemiologic and clinical data of patients with respiratory tract infections, collected retrospectively over the past 10 years at the Pediatric Emergency Department in order to analyze trends of different etiologic agents and age groups affected with the aim of having useful data for planning prevention strategies.
|
2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Antonio Gatto, Fondazione Policlinico Universitario A. gemelli, IRCCS
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 6520
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.